Hammerson PLC (HMN)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 7,783.00 |
|---|---|
| 52-week range | 5,705.00 – 8,674.00 |
| Return, 1 month / 3 months | +4.7% / −5.1% |
| Return, 1 year / 3 years | +8.7% / +57.9% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 23.3% |
| Worst drawdown (1 year) | -16.7% |
| Average daily value traded | 1,898.41M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hammerson PLC is a property company that owns and manages shopping centres and retail destinations, mainly in the United Kingdom and Ireland. Its centres bring together shops, restaurants and leisure space, and the company works with retailers and brands as tenants while managing and improving the buildings it owns. Hammerson is based in London and operates as a real estate investment trust, deriving income chiefly from rents paid by the businesses that occupy its retail properties.
The shares are listed on the Johannesburg Stock Exchange in South Africa under the code HMN, and the price on this page is in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hammerson PLC (HMN) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 7,783.00 on 27 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 72 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.7% and over the last three months it fell 5.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.2% | ||
| From 52-week high | -9.0% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.1% | ||
| 6-month return | 4.8% | ||
| 12-month return, skipping the last month | 3.8% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.7% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,898.41M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | +4.7% |
| 3 months | −5.1% |
| 6 months | +4.8% |
| 1 year | +8.7% |
| 3 years | +57.9% |
| 5 years | +22.9% |
Signals
| 50-day / 200-day average | 7,655.49 / 7,616.32 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 178.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Oct 2022 | ZAC 3.8975 |
| 30 Mar 2022 | ZAC 39.4120 |
| 27 Oct 2021 | ZAC 4.0242 |
| 31 Mar 2021 | ZAC 4.0841 |
| 18 Nov 2020 | ZAC 4.0383 |
| 18 Mar 2020 | ZAC 162.0700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.